Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dry Eye Sufferers Can Find Relief at Bellevue LASIK and Cataract with Breakthrough LipiFlow® Treatment
  • USA - English


News provided by

Bellevue LASIK & Cornea

Jul 10, 2014, 17:05 ET

Share this article

Share toX

Share this article

Share toX

Bellevue LASIK and Cataract offers the latest technological advances in patient eye care.
Bellevue LASIK and Cataract offers the latest technological advances in patient eye care.

Bellevue, WA (PRWEB) July 10, 2014 -- Bellevue LASIK and Cataract today announced the availability of LipiFlow®, a breakthrough treatment for dry eye sufferers. LipiFlow, from TearScience, treats the root cause of the most common form of dry eye disease, called Evaporative Dry Eye. This type of dry eye occurs when oil glands located in the eyelid do not secrete the oil required to protect the water portion of the eyes’ tears from evaporating too quickly.

Our practice is committed to using the most advanced technology to help our patients achieve ocular comfort and optimal vision. LipiFlow provides the technological leap in dry eye treatments that the eye care industry has been waiting for

Post this

Kent Leavitt, MD, owner and surgeon at Bellevue Lasik and cataract explains “We have seen a dramatic increase in the occurrence of Evaporative Dry Eye Disease due to the change in our visual tasks over the past decade. With prolonged use of computers, tablets, phones and similar technology our blink rates have diminished which exacerbates the Dry Eye problem.”

LipiFlow uses directed heat and gentle pulsatile pressure to unblock obstructed Meibomian (oil) glands located in the eyelids. By unblocking these glands during a 12-minute in-office procedure, LipiFlow allows the Meibomian glands to resume their natural production of oily lipids needed for a healthy tear film. LipiFlow was developed as a result of 30 years of research and collaboration with more than 50 scientists and professionals and millions of dollars of investment.

Bellevue LASIK and Cataract is a local comprehensive ophthalmology practice that focuses on providing the highest quality vision care using the safest in proven technology. This practice was recently voted the best eye care facility in 425 magazine. Bellevue LASIK and Cataract is among the first clinics to offer the LipiFlow treatment in the greater Seattle region.

“We are proud to offer LipiFlow, a safe, effective treatment for our dry eye patients,” said Kent Leavitt, MD. “Our practice is committed to using the most advanced technology to help our patients achieve ocular comfort and optimal vision. LipiFlow provides the technological leap in dry eye treatments that the eye care industry has been waiting for.”

TearScience’s assessment and treatment devices include the LipiView® Ocular Surface Interferometer and the LipiFlow ® Thermal Pulsation System. LipiView provides detailed digital images of a dry eye patient’s tear film for the physician to assess the lipid layer. LipiView is used by physicians in conjunction with a dry eye questionnaire and a Meibomian gland evaluation to determine if a patient suffers from Evaporative Dry Eye. LipiView also helps identify if the patient is a partial blinker, which may negatively impact the spread of oils across the eye’s surface. LipiView, a new dry eye screening device, helps the physician gain unprecedented insight into patients’ disease. It helps the patient visualize their tear film and better understand why they feel symptomatic.

Evaporative Dry Eye Disease, which causes eyes to feel dry, irritated, gritty, and may even cause blurred vision or sensitivity to sunlight, is a chronic, progressive disease that may worsen over time. Evaporative Dry Eye differs from Aqueous-Deficient Dry Eye, where the body is not able to produce adequate moisture to keep the eyes lubricated and is typically treated with pharmaceuticals like Restasis.

Dry Eye patients should undergo a complete evaluation to determine the type of dry eye they have. In TearScience’s multi-center, randomized, controlled clinical study, 79 percent of patients reported an improvement in overall dry eye symptoms within four weeks of a single LipiFlow treatment.

Click here to watch videos on how Lipiflow works or take the LipiFlow Dry Eye Quiz.

1. Lemp MA, et al. Distribution of aqueous deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012:31(5):472-478

Bellevue LASIK and Cataract
Bellevue LASIK and Cataract offers the latest technological advances in patient eye care. Lead by Kent Leavitt, MD and, Christina Farag, OD, Bellevue LASIK and Cataract offers state of the art technology provided by a well trained professional staff, committed to providing the best possible eye care for patients’ needs. For more information, visit Bellevue LASIK and Cataract’s web page. Bellevue-Lasik.com

Leslie Hargis, Bellevue LASIK & Cornea, http://bellevue-lasik.com, +1 425.450.6990, [email protected]

Modal title

The TearScience® experience includes a three-part comprehensive evaluation. This evaluation provides key information that your doctor uses in his or her determination of your Dry Eye diagnosis.
The TearScience® experience includes a three-part comprehensive evaluation. This evaluation provides key information that your doctor uses in his or her determination of your Dry Eye diagnosis.
Meibomian Gland Evaluation
Meibomian Gland Evaluation
LipiFlow Thermal Pulsation treats evaporative dry eye patients with a 12-minute, in-office procedure.
LipiFlow Thermal Pulsation treats evaporative dry eye patients with a 12-minute, in-office procedure.
The TearScience® experience includes a three-part comprehensive evaluation. This evaluation provides key information that your doctor uses in his or her determination of your Dry Eye diagnosis. Meibomian Gland Evaluation LipiFlow Thermal Pulsation treats evaporative dry eye patients with a 12-minute, in-office procedure.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.